Pfizer CEO Albert Bourla announced that the Omicron vaccine will be ready in March and the company has already started manufacturing the doses. Bourla explained in an interview with Cnbc that the vaccine will also be effective against the other variants of Covid that are circulating.
‘Ema has started evaluating a marketing authorization application for the oral antiviral medicine Paxlovid. The question is from Pfizer Europe. This was announced by the EU Agency. The result is expected in the coming weeks.
breaking latest news © Copyright ANSA